Swedish Orphan Profile

26.80
USD 0.00  0.00%
78%
0%

Swedish Orphan Summary

Swedish Orphan Biovitrum AB (BIOVF) is traded on OTC Market in USA. It is located in Tomtebodav?gen 23A and employs 816 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 7.4 B. Swedish Orphan Biovitrum AB has 269.12 M outstanding shares. SWEDISH ORPHAN BI has accumulated about 197.05 M in cash with 144.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Swedish Orphan Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 26.8HorizonTargetOdds Above 26.8
73.23%30 days 26.80 26.60%
Based on normal probability distribution, the odds of Swedish Orphan to move above current price in 30 days from now is about 26.6% (This Swedish Orphan Biovitrum AB probability density function shows the probability of Swedish Orphan Stock to fall within a particular range of prices over 30 days) .

Top Holders

Swedish Orphan Biovi Risk Profiles

Key Fundamentals

Swedish Orphan Against Markets

Current Ratings

Swedish Orphan 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
45 
Equity ratings for Swedish Orphan Biovitrum AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan is traded on OTC Market in USA. more
NameSwedish Orphan Biovitrum AB
CEOGeoffrey McDonoughView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressTomtebodav?gen 23A
ExchangeOTC Market
SectorHealthcare
BenchmarkDOW
Websitewww.sobi.com
Phone46 86 97 20 00
CurrencyUSD - US Dollar

Did you try this?

Run Efficient Frontier Now
   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Efficient Frontier

Directors

Swedish Orphan Corporate Directors
Hans Wigzell Independent Director
Lennart Johansson Director
Annette Clancy Independent Director
Check also Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.